中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
Piers-Grubbs第二代催化剂 |
Dichloro[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene][(tricyclohexylphosphoranyl)methylidene]ruthenium(II) tetrafluoroborate |
832146-68-6 |
C40H60BCl2F4N2PRu |
|
Pht-L-天冬酰胺 |
<i>N</i><sup>2</sup>,<i>N</i><sup>2</sup>-phthaloyl-L-asparagine |
42406-52-0 |
C12H10N2O5 |
|
Phlorin; 根皮酚 1-O-beta-D-葡糖甙 |
Phlorin |
6736-49-8 |
C12H16O8 |
|
PhiKan-083盐酸盐 |
1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine |
880813-36-5 |
C16H18N2 |
|
Phenoprol胺盐酸盐 |
Phenoprolamine Hydrochloride |
93933-71-2 |
C21H30ClNO3 |
|
Pgc钯合金 |
—— |
107373-32-0 |
Au2Ca10Ga10Pd76 |
|
Pexacerfont; 8-(6-甲氧基-2-甲基-3-吡啶基)-2,7-二甲基-N-[(1R)-1-甲基丙基]吡唑并[1,5-a]-1,3,5-三嗪-4-胺 |
[14C]-Pexacerfont |
459856-18-9 |
C18H24N6O |
|
Penduletin;4',5-二羟基-3,6,7-三甲氧基黄酮 |
penduletin |
569-80-2 |
C18H16O7 |
|
Paull酮 |
paullone |
142273-18-5 |
C16H12N2O |
|
Paprotrain; (alphaZ)-alpha-(3-吡啶基亚甲基)-1H-吲哚-3-乙腈 |
(Z)-2-(1H-indol-3-yl)-3-(pyridin-3-yl)acrylonitrile |
57046-73-8 |
C16H11N3 |
|
Panduratin A; rel-(2,6-二羟基-4-甲氧基苯基)[(1R,2S,6R)-3-甲基-2-(3-甲基-2-丁烯-1-基)-6-苯基-3-环己烯-1-基]甲酮 |
(+)-Panduratin A |
89837-52-5 |
C26H30O4 |
|
Palmitoleoy乙醇胺 |
Palmitoleoyl Ethanolamide |
94421-67-7 |
C18H35NO2 |
|
Palbociclib中间体 |
6-bromo-8-cyclopentyl-5-methyl-2-(methylsulfinyl)pyrido[2,3-d]pyrimidin-7(8H)-one |
571188-81-3 |
C14H16BrN3O2S |
|
PYRAZOLOACRIDINE无结构图 |
Pyrazoloacridine methanesulfonate |
99009-21-9 |
CH4O3S*C19H21N5O3 |
|
PYR41抑制剂 |
Ethyl 4-[4-[(5-nitrofuran-2-yl)methylidene]-3,5-dioxopyrazolidin-1-yl]benzoate |
418805-02-4 |
C17H13N3O7 |
|
PX20606 反式异构体 |
PX-20606 |
1268244-85-4 |
C29H22Cl3NO4 |
|
PV坚牢红HFT |
Benzoic acid, 2-[[3-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-hydroxy-1-naphthalenyl]azo]-, methyl ester |
6985-92-8 |
C26H19N5O5 |
|
PV坚牢红HB |
Calcium;4-[[3-[[2-hydroxy-3-[(4-methoxyphenyl)carbamoyl]naphthalen-1-yl]diazenyl]-4-methylbenzoyl]amino]benzenesulfonic acid;4-[[3-[[3-[(4-methoxyphenyl)carbamoyl]-2-oxidonaphthalen-1-yl]diazenyl]-4-methylbenzoyl]amino]benzenesulfonate |
—— |
C64H50CaN8O14S2 |
|
PVM/MA共聚物乙酯 |
Gantrez ES 225 |
25087-06-3 |
C9H14O5 |
|
PVM/MA共聚物 |
vorasidenib |
1644545-52-7 |
C14H13ClF6N6 |
|
PTH-天冬酰胺 |
D,L-asparagine N-phenylthiohydantoin |
5624-08-8 |
C11H11N3O2S |
|
PTH-DL-α-氨基异丁酸 |
5,5-Dimethyl-3-phenyl-2-thiohydantoin |
21083-30-7 |
C11H12N2OS |
|
PTH-DL-2-氨基丁酸 |
5-ethyl-3-phenyl-2-thioxoimidazolidin-4-one |
66256-32-4 |
C11H12N2OS |
|
PTCBI(顺反混合物) |
Benzimidazole perylene |
79534-91-1 |
C27H18N2 |
|
PTC-209抑制剂 |
PTC-209 |
315704-66-6 |
C17H13Br2N5OS |
|
PSS-联苯基乙烯基硅氧基-七环戊基取代物 |
Pss-(diphenylvinylsilyloxy)heptaclopent& |
312693-49-5 |
C49H76O13Si9 |
|
PSS-甲苯基乙烯基硅氧基-七环戊基取代物 |
Pss-methylphenylvinylsilyloxy-heptacycl& |
312693-48-4 |
C44H74O13Si9 |
|
PSS-烯丙基-七环戊基取代 |
PSS-Allyl-Heptacyclopentyl substituted |
205131-81-3 |
C38H68O12Si8 |
|
PSS-烯丙基-七异丁基取代 |
PSS-Allyl-Heptaisobutyl substituted |
351003-00-4 |
C31H68O12Si8 |
|
PSS-氯丙基-异丁基取代 |
(3-chloropropyl)hepta(isobutyl)octasilsesquioxane |
480438-84-4 |
C31H69ClO12Si8 |
|
PSS-八[2-(氯二甲基硅烷基)乙基]取代 |
octa(chlorodimethylsilylethyl)silsesquioxane |
243146-51-2 |
C32H80Cl8O12Si16 |
|
PSS-八(2-二氯甲基硅基乙基)取代 |
1,3,5,7,11,13,15-octakis[2-(dichloromethylsilyl)ethyl]pentacyclo[9.5.1.1<sup>3,9</sup>.1<sup>5,15</sup>.1<sup>7,13</sup>]octasiloxane |
314727-18-9 |
C24H56Cl16O12Si16 |
|
PSS-[2-(3-环己烯)乙基]-七环戊基取代 |
Pss-(2-(3-cyclohexen-1-YL)ethyl)heptacy& |
307496-19-1 |
C43H76O12Si8 |
|
PSS-[2-(3,4-环氧环己基)乙基]-取代七异丁基 |
1,3,5,7,9,11,13-Heptakis(2-methylpropyl)-15-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosane |
445379-56-6 |
C36H76O13Si8 |
|
PSS-[2-(3,4-环氧树脂环己基)乙基]-七环戊基取代 |
1,3,5,7,9,11,13-heptacyclopentyl-15-[2-(7-oxabicyclo[4.1.0]heptan-3-yl)ethyl]-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosane |
307496-16-8 |
C43H76O13Si8 |
|
PSS-[1-(乙基十一酸)]-七环戊基取代 |
Pss-(1-(ethyl undecanoate))-heptacyclop& |
308103-65-3 |
C48H88O14Si8 |
|
PSS-Octa(2-三氯甲硅烷基乙基)取代 |
1,3,5,7,11,13,15-octakis[2-(trichlorosilyl)ethyl]pentacyclo[9.5.1.1<sup>3,9</sup>.1<sup>5,15</sup>.1<sup>7,13</sup>]octasiloxane |
214675-88-4 |
C16H32Cl24O12Si16 |
|
PSS-(4-(氯甲基)苯基)-七环戊基取代 |
Pss-(4-(chloromethyl)phenyl))-heptacycl& |
307496-35-1 |
C42H69ClO12Si8 |
|
PSS-(3-缩水甘油基)丙氧基-取代七异丁基 |
Pss-(3-glycidyl)propoxy-heptaisobutyl S& |
444315-17-7 |
C34H74O14Si8 |
|
PSS-(3-环己基)-七环戊基取代 |
Pss-(3-cyclohexen-1-YL)-heptacyclopenty& |
307496-29-3 |
C41H72O12Si8 |
|
PSS-(3-巯基)丙基-七异丁基取代 |
1-(3-mercapto)propyl-3,5,7,9,11,13,15-isobutylpentacyclo[9.5.1.1<sup>3,9</sup>.1<sup>5,15</sup>.1<sup>7,13</sup>]octasiloxane |
480438-85-5 |
C31H70O12SSi8 |
|
PSS-(2-(反式-3,4-环己二醇)乙基)-七异丁基取代 |
Pss-(2-(trans-3 4-cyclohexanediol)ethyl& |
480439-48-3 |
C36H78O14Si8 |
|
PSS-(1-丙基异丁烯酸)-七异丁基取代 |
Pss-(1-propylmethacrylate)-heptaisobuty& |
307531-94-8 |
C35H74O14Si8 |
|
PSS-(1-(甲基丙酸))-七环戊基取代 |
methyl 3-(3,5,7,9,11,13,15-heptacyclopentyl-2,4,6,8,10,12,14,16,17,18,19,20-dodecaoxa-1,3,5,7,9,11,13,15-octasilapentacyclo[9.5.1.13,9.15,15.17,13]icosan-1-yl)propanoate |
308103-64-2 |
C39H70O14Si8 |
|
PSN375963盐酸盐 |
PSN375963 |
388575-52-8 |
C17H23N3O |
|
PRT-060318(PRT318)中间体 |
2-chloro-4-(3-methylanilino)pyrimidine-5-carboxylic acid |
227449-26-5 |
C12H10ClN3O2 |
|
PROTOPORPHYRIN營XCOBALTCHLORIDE |
Co(iii) protoporphyrin ix chloride |
102601-60-5 |
C34H32ClCoN4O4 |
|
PR171关键中间体IV |
(S)-methyl 2-((S)-2-tert.butoxycarbonyIamino-4-phenylbutanamido-4-methylpentanamido)-3-phenylpropanoate |
868539-96-2 |
C31H43N3O6 |
|
PPIase-Parvulin抑制剂 |
1,3,6,8-tetrahydro-1,3,6,8-tetraoxo-benzo[lmn][3,8]phenanthroline-2,7-diacetic acid 2,7-diethyl ester |
64005-90-9 |
C22H18N2O8 |
|
PPG-6-山梨醇聚醚-245 |
PPG-6-Sorbeth-245 |
56449-05-9 |
C36H74O18 |
|